Order Article Reprints

Crispo F, Vassallo A, Faraone I, Santarsiere A, Chiummiento L, Martinelli M, Cascelli N, Fernàndez-Busquets X, Miglionico R, Nigro I, et al. Repurposing HIV-Protease Inhibitor Precursors as Anticancer Agents: The Synthetic Molecule RDD-142 Delays Cell Cycle Progression and Induces Autophagy in HepG2 Cells with Enhanced Efficacy via Liposomal Formulation. International Journal of Molecular Sciences. 2025; 26(21):10305. https://doi.org/10.3390/ijms262110305

Crispo, Fabiana, Antonio Vassallo, Immacolata Faraone, Alessandro Santarsiere, Lucia Chiummiento, Mara Martinelli, Nicoletta Cascelli, Xavier Fernàndez-Busquets, Rocchina Miglionico, Ilaria Nigro, and et al. 2025. "Repurposing HIV-Protease Inhibitor Precursors as Anticancer Agents: The Synthetic Molecule RDD-142 Delays Cell Cycle Progression and Induces Autophagy in HepG2 Cells with Enhanced Efficacy via Liposomal Formulation" International Journal of Molecular Sciences 26, no. 21: 10305. https://doi.org/10.3390/ijms262110305

Crispo, F., Vassallo, A., Faraone, I., Santarsiere, A., Chiummiento, L., Martinelli, M., Cascelli, N., Fernàndez-Busquets, X., Miglionico, R., Nigro, I., Caddeo, C., & Armentano, M. F. (2025). Repurposing HIV-Protease Inhibitor Precursors as Anticancer Agents: The Synthetic Molecule RDD-142 Delays Cell Cycle Progression and Induces Autophagy in HepG2 Cells with Enhanced Efficacy via Liposomal Formulation. International Journal of Molecular Sciences, 26(21), 10305. https://doi.org/10.3390/ijms262110305